Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SAfiledCriticalRoussel Uclaf SA
Priority to FR8217282ApriorityCriticalpatent/FR2534588B2/en
Publication of FR2534588A2publicationCriticalpatent/FR2534588A2/en
Application grantedgrantedCritical
Publication of FR2534588B2publicationCriticalpatent/FR2534588B2/en
C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
FR8217282A1982-10-151982-10-15
NOVEL OXIMES DERIVED FROM ERYTHROMYCIN, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS MEDICAMENTS
ExpiredFR2534588B2
(en)
NOVEL STEROIDS COMPRISING A SPIRANIC CYCLE IN POSITION 17, THEIR PREPARATION METHOD, THEIR APPLICATION AS MEDICAMENTS AND THE COMPOSITIONS CONTAINING THEM